FDAnews
www.fdanews.com/articles/175763-fda-slams-iv-specialty-over-insanitary-conditions

FDA Slams I.V. Specialty Over Insanitary Conditions

March 16, 2016

I.V. Specialty of Austin, Texas landed in hot water with the FDA over insanitary conditions uncovered during a recent inspection. 

According to an agency alert, inspectors discovered poor sterile production practices at the company, and recommended a halt to sterile production until appropriate corrective actions are implemented. The FDA also urged a recall of all non-expired drug products intended to be sterile.

I.V. Specialty, however, has not taken either suggested action, and the agency has alerted healthcare professionals to avoid using the company’s products. I.V. Specialty did not return a request for comment by press time. Read the I.V. Specialty alert here: www.fdanews.com/03-10-16-IVSpecialtyAlert.pdf.